Professional Documents
Culture Documents
Vasoactive peptides
Vasodilators:
Bradykinin
Natriuretic peptides
Vasoactive intestinal
peptide
Substance P
Calcitonin gene
related peptide
Vasoconstrictors
Angiotensin II
It acts on the kidney to cause renal vasoconstriction, ↑ Na+
reabsorption & inhibit renin release. Stimulate release of aldosterone
form adrenal gland causing ↑ Na+ reabsorption ↑ fluid volume ↑ BP.
Endothilins
Vasoconstriction and decrease glomerular filtration rate and sodium
and water excretion. They cause potent contraction of tracheal and
bronchial smooth muscle.
Neuropeptide Y
NPY produces a variety of CNS effects, including increased feeding,
respiratory depression, activation of the hypothalamic- pituitary-
adrenal axis & vasoconstriction of cerebral blood vessels
CVS – Positive chronotropic and inotropic actions on the heart and
hypertension .
Kidneys – Potent renal vasoconstrictor and suppresses renin secretion,
but can cause diuresis and natriuresis
Urotensin II
When the urotensin II receptor is activated through an ICV injection of
urotensin II it causes an increase of corticotropin releasing factor which lead
to increased plasma levels of adrencorticotropic hormones.
Vasodilators
Kinins
Arteriolar dilation: inhibit arteriolar smooth muscles & causes the release of
PGE2 and prostacyclin
Venous contraction: stimulation of venous smooth muscles & release PGF 2α
Inflammation.
Natriuretic peptides (ANP, BNP)
Both ANP and BNP bind preferentially to NPR-A, utilize cyclic guanosine
monophosphate (cGMP) as the intracellular messenger and produces effects
such as diuresis, natriuresis, vasodilation, and inhibition of aldosterone
synthesis and renin secretion as a circulating hormone, and thereby play an
important role in regulating blood pressure and blood volume.
Vasoactive Intestinal Peptide (VIP)
GIT – induce smooth muscle relaxation, dilating peripheral